SCHEMBL8851136

SCHEMBL8851136

CC(C)NCCN(C)C1CC[N]CC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8851382 0.90
SCHEMBL18233610 0.87 PIK3CD (0.35) PIK3CD
SCHEMBL8851165 0.79 PRMT3 (0.39)
SCHEMBL8851153 0.79
SCHEMBL8851141 0.79 SLC6A2 (0.33) PIK3CD
SCHEMBL18233621 0.79 PIK3CD (0.55) PIK3CD
SCHEMBL8851455 0.78 DRD3 (0.36)
SCHEMBL8852160 0.76 SAT1 (0.32)
SCHEMBL18236762 0.76 PIK3CD (0.33) PIK3CD
SCHEMBL19397727 0.74 KAT2B (0.37) PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5618814-A Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds DR. KARL THOMAE GMBH (DE) 1997-04-08 US disclosed
EP-0645390-A1 Trisubstituted pyrimido 5,4-d pyrimidines for modulating multidrug resistance, drugs containing these compounds and processes for their preparation Dr. Karl Thomae GmbH (DE) 1995-03-29 EP disclosed